Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Symptoms, Laboratory Parameters and Long-Term Follow-up in a National DADA2 Cohort.
Andriessen MVE, Legger GE, Bredius RGM, van Gijn ME, Hak AE, Muller PCEH, Kamphuis S, Klouwer FCC, Kuijpers TW, Leavis HL, Nierkens S, Rutgers A, van der Veken LT, van Well GTJ, Mulders-Manders CM, van Montfrans JM. Andriessen MVE, et al. Among authors: bredius rgm. J Clin Immunol. 2023 Oct;43(7):1581-1596. doi: 10.1007/s10875-023-01521-8. Epub 2023 Jun 5. J Clin Immunol. 2023. PMID: 37277582 Free PMC article. Review.
Anti-T-lymphocyte globulin exposure is associated with acute graft-versus-host disease and relapse in pediatric acute lymphoblastic leukemia patients undergoing hematopoietic stem cell transplantation: a multinational prospective study.
Oostenbrink LVE, Von Asmuth EGJ, Jol-van der Zijde CM, Jansen-Hoogendijk AM, Vervat C, Bredius RGM, Van Tol MJD, Schilham MW, Sedlacek P, Ifversen M, Balduzzi A, Bader P, Peters C, Moes DJAR, Lankester AC. Oostenbrink LVE, et al. Among authors: bredius rgm. Haematologica. 2024 May 9. doi: 10.3324/haematol.2023.284632. Online ahead of print. Haematologica. 2024. PMID: 38721739 Free article.
Exposure-response analysis of alemtuzumab in pediatric allogeneic HSCT for nonmalignant diseases: the ARTIC study.
Achini-Gutzwiller FR, Schilham MW, von Asmuth EGJ, Jansen-Hoogendijk AM, Jol-van der Zijde CM, van Tol MJD, Bredius RGM, Güngör T, Lankester AC, Moes DJAR. Achini-Gutzwiller FR, et al. Among authors: bredius rgm. Blood Adv. 2023 Aug 22;7(16):4462-4474. doi: 10.1182/bloodadvances.2022009051. Blood Adv. 2023. PMID: 37285798 Free PMC article.
Development and Validation of an Efficient and Highly Sensitive Enzyme-Linked Immunosorbent Assay for Alemtuzumab Quantification in Human Serum and Plasma.
Achini-Gutzwiller FR, Jol-van der Zijde CM, Jansen-Hoogendijk AM, Lankester AC, Bredius RGM, van Tol MJD, Moes DJAR, Schilham MW. Achini-Gutzwiller FR, et al. Among authors: bredius rgm. Ther Drug Monit. 2023 Feb 1;45(1):79-86. doi: 10.1097/FTD.0000000000001037. Epub 2022 Sep 23. Ther Drug Monit. 2023. PMID: 36150715 Free PMC article.
T and NK Cells in IL2RG-Deficient Patient 50 Years After Hematopoietic Stem Cell Transplantation.
Melsen JE, van Ostaijen-Ten Dam MM, van den Akker EB, Welters MJP, Heezen KC, Pico-Knijnenburg I, Kolijn PM, Bredius RGM, van Doorn R, Langerak AW, Schilham MW, Lankester AC. Melsen JE, et al. Among authors: bredius rgm. J Clin Immunol. 2022 Aug;42(6):1205-1222. doi: 10.1007/s10875-022-01279-5. Epub 2022 May 9. J Clin Immunol. 2022. PMID: 35527320 Free PMC article.
125 results